Screener
BioAmber
BIOABioAmber is a biotechnology company in the healthcare sector trading on XNYS, led by CEO Kristen Fortney, with a market cap of $355.7M.
$355.7M+98.4%
We’re still putting together BioAmber’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move BioAmber up the queue, and we’ll analyze its filings next.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$1.5M
EPS estimate-$0.66
Profile
CountryUnited States of America
Listed2024
CEOKristen Fortney
SectorHealthcare
IndustryBiotechnology
Websitebioagelabs.com
FilingsSEC EDGAR